ROBERT LANE: Open Payments
NPI 1114944683 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 10 payments from 9 companies in 2025. Trend: 2023 $63 · 2024 $0 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $147 |
| Corium, LLC | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| Alkermes, Inc. | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| Teva Pharmaceuticals USA, Inc. | 1 | $89 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| Radius Health, Inc. | 1 | $20 |
Products named: CAPLYTA, Azstarys, INGREZZA, Auvelity, LYBALVI, COBENFY, Tymlos.
Industry payments across IN — which companies pay providers there.
